Patent Strengthens Company Intellectual Property Portfolio

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

Additional Technologies Strengthen Pipeline

TapImmune, Inc. ( OTCBB: TPIM) announced that their TAP incorporated vaccine for the treatment of cancer was recently reviewed by a third party research article in the Journal of Investigative Dermatology, which confirmed that the company’s vaccine should be considered as a therapy for cancer. The article, entitled, “Restoration of the Expression of Transporters Associate [...]

TPIM is a biotechnology company, and we all know those can move fast!  In fact one of my biggest winners of all time was Dendreon (DNDN).  I did numerous alerts on it at under $5 and literally overnight it shot to $18 and over the next few days went at high as $25!!!

Every bio company is one cancer drug away from hitting it big and I believe TPIM is getting close.  These companies can double, triple even quadruple over night!  I've seen it happen many times.

TPIM has been featured in Business Week, Popular Mechanics and ABC News.

Cancer is very serious and TPIM has developed a vaccine that helps the body move cancer makers to the surface of cells so that the body can detect and fight these cells.
Start your research on TPIM fast at: http://www.tapimmune.com

TapImmune, Inc., a development stage biotechnology company, develops therapeutics and vaccines in the areas of oncology and infectious disease. The company conducts preclinical studies using its TAP gene technology in combination with an in-licensed adeno virus. Its TAP cancer vaccine (transporters of antigen processing) would be used for the treatment of breast cancer, prostate cancer, lung cancer, liver cancer, melanoma, renal cancer, and colorectal cancer. TapImmune also develops vaccines for infectious diseases using its TAP gene technology and an in-licensed modified vaccinia ankora virus. It has strategic relationships wit University of British Columbia; Crucell Holland B.V.; Molecular Medicine BioServices, Inc.; National Institute of Allergy and Infectious Diseases; and Parc Place Investments AC. The company was founded in 1999. It was formerly known as GeneMax Corp. and changed its name to TapImmune, Inc. in June 2007. TapImmune is based in Vancouver, Canada.

Currency in Millions of U.S. Dollars	As of:	Dec 31 2004 Restated	Dec 31 2005 Restated	Dec 31 2006 Restated	Dec 31 2007	4-Year Trend
Cost of Goods Sold	0.1	0.2	--	--
GROSS PROFIT	-0.1	-0.2	--	--
Selling General & Admin Expenses, Total	1.2	0.5	0.6	2.1
R&D Expenses	1.0	0.2	0.3	0.4
Depreciation & Amortization, Total	0.0	0.0	0.0	0.0
OTHER OPERATING EXPENSES, TOTAL	2.2	0.8	0.9	2.5
OPERATING INCOME	-2.4	-1.0	-0.9	-2.5
Interest Expense	-0.1	-0.1	-0.4	-1.4
Interest and Investment Income	--	0.0	--	--
NET INTEREST EXPENSE	-0.1	-0.1	-0.4	-1.4
Other Non-Operating Income (Expenses)	-0.2	0.0	--	--
EBT, EXCLUDING UNUSUAL ITEMS	-2.7	-1.1	-1.3	-3.9
Other Unusual Items, Total	--	0.1	0.0	--
Other Unusual Items	--	0.1	0.0	--
EBT, INCLUDING UNUSUAL ITEMS	-2.7	-1.0	-1.3	-3.9
Earnings from Continuing Operations	-2.7	-1.0	-1.3	-3.9
NET INCOME	-2.7	-1.0	-1.3	-3.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS	-2.7	-1.0	-1.3	-3.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS	-2.7	-1.0	-1.3	-3.9

Chart Indicators

Ind.	short	Inter	Long
EMA	VBu	VBu	VBu
MACD	VBu	VBu	VBu
RSI		Bu
TDD		Bu
Fibs	VBu	Be	Bu
Highs	VBu	N	N
Lows	N	N	Be
Trends	Bu	Bu	N
Stoch.	VBe

Overall	Short	Intermediate	Long
Bullish (0.38)	Bullish (0.43)	Bullish (0.36)	Bullish (0.35)

Recent CandleStick Analysis
Bullish

Date	Candle
May-28-2008	Bullish Engulfing
May-27-2008	Inverted Hammer

Markets:

	<th colspan="3"> Analysis </th> Overall <th> </th> 0.12 Short term <th> </th> 0.12 Intermediate <th> </th> 0.23 Long term <th> </th> 0.03 <th colspan="4"> Chart Indicators </th>   ST IT LT EMA <th> </th> <th> </th> <th> </th> MACD <th> </th> <th> </th> <th> </th> RSI   <th> </th> 3pD   <th> </th> Fibon. <th> </th> <th> </th> <th> </th> Highs <th> </th> <th> </th> <th> </th> Lows <th> </th> <th> </th> <th> </th> Trends <th> </th> <th> </th> <th> </th> Stoch. <th> </th> <th colspan="2"> Key </th> <th> </th> Very Bullish <th> </th> Bullish <th> </th> Neutral <th> </th> Bearish <th> </th> Very Bearish
	Fast 0.01 <th> </th> ST IT LT Slow 0.01 <th> </th> <th> </th> Tops <th> ! </th> <th> </th> <th> </th> Bottoms <th> </th> <th> </th> <th> </th>
	Overbought buried <th> </th>
	14-3-3 Stochastic 0.49